Govoni N; Parmeggiani A; Galeati G; Penazzi P; De Iasio R; Pagotto U; Pasquali R; Tamanini C; Seren E., Acyl ghrelin and metabolic hormones in pregnant and lactating sows., «REPRODUCTION IN DOMESTIC ANIMALS», 2007, 42, pp. 39 - 43 [Scientific article]
Cervino C.; Pasquali R.; Pagotto U., Cannabinoid receptor antagonists and the metabolic syndrome: Novel promising therapeutical approaches., «MINI-REVIEWS IN MEDICINAL CHEMISTRY», 2007, 7, pp. 21 - 30 [Scientific article]
Vicennati V; Ghenghini S; Iaso R; Pasqui F; Pagotto U; Pasquali R., Circulating obestatin levels and the grelin/obestatin ratio in obese women, «EUROPEAN JOURNAL OF ENDOCRINOLOGY», 2007, 157 (3), pp. 295 - 301 [Scientific article]
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R., Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome., «THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM», 2007, 92, pp. 2066 - 2073 [Scientific article]
Pagotto U; Gambineri A; Vicennati V; Pasquali R, Involvement of the endocannabinoid system in metabolism and fertility, in: NESTLER JE DIAMANTI-KANDARAKIS E PASQUALI R AND PANIDIS D, Contemporary Endocrinology: Insulin resistance and polycystic ovary syndrome: pathogenesis, evaluation, and treatment, TOTOWA, New Jersey, Humana Press Inc., 2007, pp. 387 - 415 [Chapter or essay]
Campana D.; Nori F.; Pagotto U.; De Iasio R.; Morselli-Labate AM.; Pasquali R.; Corinaldesi R.; Tomassetti P., Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis., «CLINICAL ENDOCRINOLOGY», 2007, 67, pp. 761 - 766 [Scientific article]
Cota D; Steiner MA; Marsicano G; Cervino C; Herman JP; Grübler Y; Stalla J; Pasquali R; Lutz B; Stalla GK; Pagotto U., Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function., «ENDOCRINOLOGY», 2007, 148, pp. 1574 - 1581 [Scientific article]
Bellocchio L.; Vicennati V.; Cervino C.; Pasquali R.; Pagotto U., The endocannabinoid system in the regulation of cardiometabolic risk factots, «THE AMERICAN JOURNAL OF CARDIOLOGY», 2007, 100, pp. 7P - 17P [Scientific article]
Bellocchio L.; Mancini G.; Vicennati V.; Pasquali R.; Pagotto U., Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases., «CURRENT OPINION IN PHARMACOLOGY», 2006, 6, pp. 586 - 591 [Scientific article]
Seoane L.M.; Al-Massadi O.; Pazos Y.; Pagotto U.; Casanueva F.F., Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats., «JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION», 2006, 29, pp. 13 - 15 [Scientific article]
Pagotto U.; Pasquali R., Endocannabinoids and energy metabolism., «JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION», 2006, 29, pp. 66 - 76 [Scientific article]
Pagotto U.; Vicennati V.; Pasquali R., Fisiopatologia del sistema endocannabinoide: focus sul metabolismo, «IL DIABETE», 2006, 18, pp. 1 - 10 [Scientific article]
Gambineri A.; Vicennati V.; Genghini S.; Tomassoni F.; Pagotto U.; Pasquali R.; Walker B.R., Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome., «THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM», 2006, 91, pp. 2295 - 2302 [Scientific article]
Pagotto U.; Cervino C.; Vicennati V.; Marsicano G.; Lutz B.; Pasquali R., How many sites of action for endocannabinoids to control energy metabolism?, «INTERNATIONAL JOURNAL OF OBESITY», 2006, 30, pp. 39 - 43 [Scientific article]
Pagotto U.; Vicennati V.; Pasquali R., Il sistema endocannabinoide. Nuovo target terapeutico per fronteggiare l'obesità addominale e le sue comorbidità, «LA CARDIOLOGIA NELLA PRATICA CLINICA», 2006, 13, pp. 188 - 200 [Scientific article]
